Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.45 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.40 |
| ▸ | PSEN1 | P49768 | 9/20 | 0.39 |
| ▸ | PSEN2 | P49810 | 9/20 | 0.39 |
| ▸ | APH1B | Q8WW43 | 9/20 | 0.39 |
| ▸ | NCSTN | Q92542 | 9/20 | 0.39 |
| ▸ | APH1A | Q96BI3 | 9/20 | 0.39 |
| ▸ | PSENEN | Q9NZ42 | 9/20 | 0.39 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | SLC6A9 | P48067 | 4/20 | 0.37 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.37 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL581335 | 0.88 | HRH3 (0.41) | HRH3HDAC4PSEN1PSEN2APH1B | |
| Hydrochloric Acid SCHEMBL581471 | 0.84 | HRH3 (0.35) | HRH3HDAC4PSEN1PSEN2APH1B | |
| SCHEMBL17142320 | 0.83 | HRH3 (0.48) | HRH3HDAC4PSEN1PSEN2APH1B | |
| SCHEMBL581657 | 0.81 | NOTUM (0.52) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL586566 | 0.79 | HRH3 (0.41) | HRH3HDAC4PSEN1PSEN2APH1B | |
| SCHEMBL582599 | 0.78 | HRH3 (0.35) | HRH3HDAC4PSEN1PSEN2APH1B | |
| SCHEMBL582600 | 0.78 | HRH3 (0.35) | HRH3HDAC4PSEN1PSEN2APH1B | |
| SCHEMBL581665 | 0.77 | NOTUM (0.49) | SLC6A9NOTUM | |
| SCHEMBL581816 | 0.76 | PLG (0.39) | HRH3HDAC4PSEN1PSEN2APH1B | |
| SCHEMBL581460 | 0.76 | KDM1A (0.46) | TRPM8SLC6A9NOTUM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8415378-B2 | Isoxazol-3(2H)-one analogs as therapeutic agents | ASTRAZENECA AB (SE) | 2013-04-09 | — | — | US | disclosed |
| US-20100261755-A1 | ISOXAZOL-3(2H)-ONE ANALOGS AS THERAPEUTIC AGENTS | ASTRAZENECA AB (SE) | 2010-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100261755-A1 | ISOXAZOL-3(2H)-ONE ANALOGS AS THERAPEUTIC AGENTS | NR4A3, CBR3, OXER1 | HRH3 394/4885HDAC4 39/4885PSEN1 4680/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.